Business Wire

ZTE First-Quarter Profit Reaches RMB950 Million After Improvements in Operating Cash Flow


ZTE Corporation (H share stock code: 0763.HK / A share stock code: 000063.SZ), a major international provider of telecommunications, enterprise and consumer technology solutions for the Mobile Internet, today announced its first quarter results for the period ending 31 March 2016.

The Group reported operating revenue of RMB21.859 billion, representing a 4.09% increase year on year. Net profit attributable to shareholders of the listed company amounted to RMB950 million, representing a 15.97% increase from the same period last year. Basic earnings per share amounted to RMB0.23. The Group’s net profit after extraordinary items, operating cash flow and net cash and cash equivalents at the end of the year all made a big progress. R&D ratio hit a historical high 13.96%.

ZTE continues to innovate in line with its M-ICT strategy and set a new record by investing 13.96% of revenue into R&D in Q1. ZTE is among the top three companies for number of PCT patents filed globally and first for the number of invention patents applied for in the mainland. ZTE has filed for more than 22,000 terminal-related patents globally, of which more than 4600 were accepted. More than 500 patent applications were related to the flagship AXON series. This is strategically significant for the internationalization of ZTE’s products, especially in Europe and North America.

In the carrier network market, with continued growth in traditional businesses including LTE and fiber optic networks, ZTE focused on developing cutting-edge technologies and sectors such as Pre5G/5G, Big Video, SDN&NFV and IOT. ZTE has become the leader in Pre5G/5G and a driver for commercial trials through deep collaborations with Softbank and China Mobile, winning the CTO choice award at MWC 2016 as a result. ZTE innovated in sectors such as SDN/NFV and next generation IOT through strategic collaborations with the mainland’s three biggest operators. ZTE’s competitiveness in Big Video also continues to increase, helping operators fulfil the dream of 4K video in the home. ZTE’s converged content delivery network (CDN) products are now commercialized in 80 locations globally with maximum concurrent capacity at 30T.

In the enterprise business, ZTE has won contracts and commenced deployment of Smart City 2.0 solutions in mainland cities including Shenyang and Huaian and has achieved breakthroughs in Europe’s high-end market. Smart rail transport is continuing to grow with major projects in Denmark, Greece and India. ZTE continues to gain competitiveness in the smart energy sector with private power line LTE wireless networks commercialized in more than ten cities in China and power line communication products and solutions breaking through in Africa.

For consumer business, network video communication products and TV set-top boxes are winning an increasing percentage of the global market. ZTE continues to sharpen focus on the high-end smartphones market with the flagship AXON series and Blade A1 series continuing to gain traction and reputation. ZTE’s innovative smart projector Spro Plus is gaining recognition in overseas markets. ZTE has recently sponsored five NBA teams in the US, the Sevilla Football Club in Europe, and will continue to partner with more sports teams to complement its progress in the overseas market. ZTE will also be launching the next-generation AXON phone in the near future.

Looking towards the next quarterly announcement, ‘multiple connections and ultra-broadband’ will become the new trademarks of the M-ICT era. Network operators will benefit from ZTE’s increased value on smart networks to support operators’ transformation from telecommunications operators to information carriers. For Enterprise business, ZTE will continue the focus on key industries and markets, streamlining standard operations and speed-up replication of successful examples to solidify its position in the industry. For Terminal business, ZTE will continue to fortify its competitiveness by increasing brand awareness. Concurrently, ZTE will continue to increase internal managerial efficiencies, especially in talent acquisition to advance core R&D to advance its M-ICT strategy journey.

Contact information

ZTE Corporation
Margrete Ma, +86 755 26775207
Edelman PR
Sofia Yip, +852 2837 4768
Gladys Kwok, +852 2837 4730

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine23.3.2018 18:28Pressemelding

Seoul Semiconductor, a global innovator of LED products and technology, announced on March 23rd that its SunLike Series natural spectrum LED product won the Gold Award at the Elektronik Product of the Year 2018 Awards, hosted by Elektronik (, a leading German electronics publication. This press release features multimedia. View the full release here: Product of the Year Award from Elektronik Magazine (SunLike) (Photo: Business Wire) As a publication specializing in electrical and electronic components, “Elektronik” is a prestigious magazine with an illustrious history and the largest number of subscribers in Germany. Over the past 20 years, they have conducted annual surveys among their subscribers to find the “most creative and innovative products.” Based on these survey results, Elektronik selects the top product that with the most impact in its corresponding field, and confers the awards accordingl

Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance23.3.2018 16:05Pressemelding

Elliott Advisors (UK) Limited (“Elliott”), which advises funds which collectively hold a significant economic interest in Bezeq The Israeli Telecommunication Corporation Ltd. (“Bezeq” or the “Company”), welcomes the proposed governance reforms announced by Bezeq last night. In its initial letter to Bezeq Interim Chairman David Granot, dated January 16, 2018, Elliott outlined the urgent need to address the Company’s serious corporate governance issues, and called for changes at the Board level that result in “the right mixture of expertise, independence and integrity for the future.” Elliott stated then, and reiterates now, its belief that “there is significant value to be unlocked if the right steps are taken to improve its corporate governance.” Bezeq has strong business fundamentals, an exemplary workforce, and great potential. Following yesterday’s announcement, Elliott highlights the changes that have occurred since January 16th. Taken together, these amount to a revolution in the

Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe23.3.2018 12:52Pressemelding

Clovis Oncology, Inc. (NASDAQ:CLVS) today announced the initiation of an early access program in Europe for rucaparib for treatment and as maintenance therapy in recurrent ovarian cancer. The program will be overseen and implemented by Caligor Coghlan, which specializes in early access to medicines. The program, to be known as the Rucaparib Access Program (RAP), will enable participation from certain countries in Europe, where permitted by applicable rules, procedures and regulatory authorities. The RAP protocol allows for rucaparib treatment of an individual patient with third-line or greater BRCA mutant epithelial, fallopian tube, or primary peritoneal ovarian cancer who has platinum-sensitive disease and is unable to tolerate further platinum-based chemotherapy or has platinum-resistant disease and needs treatment with single agent rucaparib. The RAP protocol will also provide access to rucaparib for maintenance therapy of an individual patient with recurrent epithelial ovarian, fal

CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets23.3.2018 12:50Pressemelding

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a conditional marketing authorization for Rubraca as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy. The European Marketing Authorization application for the treatment indication was based on objective response rate and duration of response results from two multicenter, single-arm, open-label clinical trials, Study 10 and ARIEL2, in women with advanced BRCA mutant ovarian cancer who had progressed after two or more prior chemotherapies. “The recommendation

Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)23.3.2018 12:46Pressemelding

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for JULUCA™ (dolutegravir 50mg [ViiV Healthcare UK Ltd]/rilpivirine 25mg [Janssen Sciences Ireland UC]). Dolutegravir/rilpivirine is a single-pill, two-drug regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase strand transfer inhibitor (INSTI).1 “We are delighted to be one step closer to bringing JULUCA™ to people living with HIV in Europe,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. “Building on our 25-year c

Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai23.3.2018 12:00Pressemelding

Aitheon, makers of the world’s first blockchain-powered platform to solve real problems by integrating AI, robotics, IoT, human specialists and cryptocurrency, announced today that executives from the company held a series of high-level briefings with world leaders at the Annual World Government Summit in Dubai. Briefings covered the benefits and challenges of AI, and revolutionary new solutions to world challenges made possible by transformative new technologies. (Read the full release at This press release features multimedia. View the full release here: Aitheon founder and CEO, Andrew Archer, and Chief Strategy Officer, Ryan Burleson, were invited to brief leaders at the Summit by Cyrus Hodes, Co-founder and Director of the AI Initiative, an undertaking of the Future Society at Harvard University’s Kennedy School. Archer and Burleson addressed a variety of AI-related topics, including the impact of AI on